UKAD releases updated statement following WADA advice on Covid-19 vaccines

To optimise for archiving, the original image and related documents associated with this article have been removed.

UKAD has released a statement following the WADA position on Covid-19 vaccines and if athletes will breach the WADA Code by having one.

UKAD initially said in a statement that WADA had confirmed the likelihood of vaccines leading to an Anti-Doping Rule Violation was extremely low but could not yet definitively advise athletes on the anti-doping status of a particular vaccine. UKAD’s new statement by Head of Science and Medicine, Nick Wojek said “UK athletes should feel confident that they will not be in breach of the World Anti-Doping Code if they receive the Pfizer-BioNTech vaccine.”

The WADA statement said “To be clear, despite the novelty of these vaccines, there is no reason to believe such vaccines would contravene anti-doping rules.” However, the statement does make it clear that each individual vaccine that receives approval will have to receive confirmation from WADA that the specific vaccine will not breach the WADA Code. Therefore, athletes are advised to either receive a vaccine that is confirmed to not breach the WADA Code or not get a specific vaccine until WADA confirms that it will not breach the Code.

Click to read the WADA statement and the UKAD statement.

You may also like

View All

Columbus Crew 2 head coach dismissed due to sexism

Major League Soccer club, Columbus Crew, have fired their reserve team head coach, Federico Higuain, after he allegedly refused to let go of a female referee’s hand, and told her: “Don’t forget, this is a man’s game”

Read More

WADA publishes 2027 Prohibited List

The World Anti-Doping Agency has published the 2027 List of Prohibited Substances and Methods, which enters into force on 1 January 2027

Read More

ITIA v Parikshit Somani

A decision in the case of the International Tennis Integrity Agency against Mr Parikshit Somani has been issued on behalf of the Independent Panel

Read More